Vioxx Research Today is a free monthly online journal that collates and summarizes the latest research about Vioxx, including details on osteoarthritis, side-effects, trials, stroke, heart attack.

Volume 2 (2005), Issue 2 (February)

1. Stable isotopically labeled internal standards in quantitative bioanalysis using liquid chromatography/mass spectrometry: necessity or not?
   Rapid Commun Mass Spectrom, 19(3): 401-7. [Abstract] [Full-text]
2. Temporal effects of a COX-2-selective NSAID on bone ingrowth.
   J Biomed Mater Res A, 72(3): 279-87. [Abstract] [Full-text]
3. Effect of cardiovascular comorbidities and concomitant aspirin use on selection of cyclooxygenase inhibitor among rheumatologists.
   Arthritis Rheum, 53(1): 12-7. [Abstract] [Full-text]
4. Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study.
   Lancet, 365(9458): 475-81. [Abstract] [Full-text]
5. The cyclooxygenase-2 inhibitor GW406381X [2-(4-ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]-pyrazolo[1,5-b]pyridazine] is effective in animal models of neuropathic pain and central sensitization.
   J Pharmacol Exp Ther, 312(3): 1161-9. [Abstract] [Full-text]
6. Valdecoxib: assessment of cyclooxygenase-2 potency and selectivity.
   J Pharmacol Exp Ther, 312(3): 1206-12. [Abstract] [Full-text]
7. Reduction of opioid-related adverse events using opioid-sparing analgesia with COX-2 inhibitors lacks documentation: a systematic review.
   Acta Anaesthesiol Scand, 49(2): 133-42. [Abstract] [Full-text]
8. Superiority of the gastroduodenal safety profile of licofelone over rofecoxib, a COX-2 selective inhibitor, in dogs.
   J Vet Pharmacol Ther, 28(1): 81-6. [Abstract] [Full-text]
9. Surgically induced accelerated local and distant tumor growth is significantly attenuated by selective COX-2 inhibition.
   Ann Thorac Surg, 79(3): 990-5; discussion 990-5. [Abstract] [Full-text]

© 2004-2008 Vioxx Research Today. All Rights Reserved.